Eco R1 Capital, LLC Graphite Bio, Inc. Transaction History

Eco R1 Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.85 - $3.21 $5.23 Million - $9.07 Million	2,826,350 Added 49.48%	8,538,446 $20.9 Million
Q4 2022 Feb 14, 2023	BUY	$2.82 - $3.59 $11.6 Million - $14.8 Million	4,129,961 Added 261.04%	5,712,096 $19 Million
Q3 2022 Nov 14, 2022	BUY	$2.82 - $4.24 $1.18 Million - $1.78 Million	419,956 Added 36.14%	1,582,135 $5.02 Million
Q2 2022 Aug 15, 2022	BUY	$2.14 - $5.23 $295,106 - $721,217	137,900 Added 13.46%	1,162,179 $3.2 Million
Q1 2022 May 16, 2022	BUY	$5.1 - $13.06 $1.71 Million - $4.38 Million	335,379 Added 48.68%	1,024,279 $5.22 Million
Q4 2021 Feb 14, 2022	BUY	$8.41 - $16.71 $5.79 Million - $11.5 Million	688,900 New	688,900 $8.56 Million

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.